A new study published in Arthritis Care & Research is the first large-scale study to document a relationship between the duration of steroid use and the cost and use of health care resources among adults with lupus.
A new study suggests that testing positive for lupus anticoagulant antibodies in the first trimester of pregnancy is the strongest predictor of pregnancy loss in women with lupus.
According to lead author, Dr. Ian Bruce, at the University of Manchester, UK, the results are encouraging
A new study published in Lupus Science & Medicine looked to see if the type of diet in people with lupus and steroid treatment are related.
A new study points to specific changes companies can make in clinical trials so that, in the future, clearer data can lead us closer to a cure.
A new study looked specifically at rates of hospitalization for serious infections among people with lupus.
The research presented brings the promise of better outcomes for pregnant women with lupus and their babies.
Not all patients who share a certain organ involvement can be treated with the same medicine at the same dose. In this piece, Foundation Medical Director Dr. Joan Merrill argues that improved classification of lupus can lead to better treatment.